Envista Holdings Corporation (NVST)
Best Momentum Stocks to Buy for August 27th
ONTO, VIRT and NVST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 27th, 2026.
Why Envista (NVST) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Envista (NVST) Upgraded to Strong Buy: Here's What You Should Know
Envista (NVST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
NVST or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Do Options Traders Know Something About Envista Stock We Don't?
Investors need to pay close attention to NVST stock based on the movements in the options market lately.
Are Investors Undervaluing Envista (NVST) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Envista (NVST) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?
Envista raises 2026 guidance as stronger sales and expanding margins lift earnings, but China pricing, tariffs and a tougher Q4 loom.
Is NVST a Buy as Earnings Rebound but Valuation Remains Above Median?
Envista's earnings rebound and raised 2026 guidance strengthen the case, but above-median valuation leaves less room for execution setbacks.
Investing in Envista (NVST)? Don't Miss Assessing Its International Revenue Trends
Examine the evolution of Envista's (NVST) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Envista Q2 Earnings Call Highlights
Envista NYSE: NVST reported second-quarter 2026 sales of $731 million, supported by 5% core revenue growth and contributions from foreign exchange and acquisitions that lifted total revenue growth to just over 7%.
NVST vs. ABT: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
